
- About WXPress
- WXPress is your window into the world of WuXi AppTec and our global partners.
- Sitemap
- Events
- Contact
- Please reach out with any business inquires.
- communications@wuxiapptec.com
True answers withstand repeated scrutiny. In the synthesis of new drug molecules, what truly stands the test of time is not a single successful reaction, but a reliable process that can be repeated, scaled up, and proven over time. This forms the most fundamental and solid foundation of true professionalism.
Several years ago, a client developing a steroidal drug candidate approached WuXi AppTec’s Research Chemistry Services (RCS) team for help with the process development of a key steroid molecule.
The client’s original route appeared feasible but had hidden limitations. It required seven steps, with an overall yield that was quite low. More critically, it suffered from significant regioselectivity issues—because steroid molecules contain multiple reactive sites, side reactions occur frequently, making it difficult to consistently obtain the desired product. Even more problematically, while the route worked at the laboratory scale, it was completely irreproducible when scaled up to the 10 to 100 gram scale, resulting in side reactions, increased impurities, and plummeted yields.
The client’s need was clear: to develop a viable route that could truly be used for scale-up.
Facing this challenge, the RCS team did not restrict its attempts to simple reaction optimization. Instead, relying on its years of accumulated expertise in steroid chemistry, it rapidly designed a brand-new synthetic route for the client.
It is worth noting that steroid chemistry is distinctly different from general organic chemistry. The types of starting materials are relatively limited, with only a handful of commercially available steroid precursors. The molecules requested by the client typically had to be derived from just one or two core starting materials. Furthermore, steroid molecules are structurally complex, featuring multiple reactive sites, making stereoselectivity difficult to control and purification challenging. However, leveraging over a decade of experience in steroid chemistry and a profound knowledge base built on synthesizing over 10,000 steroid molecules, the team accurately identified the critical reactive sites and solved the problem through innovative design.
Ultimately, the results delivered by the team far exceeded the client’s expectations. The route was shortened from seven steps to three, and the overall yield more than doubled. The process was validated at the tens-gram scale in a single run and was well recognized by the client.

Image Source: 123RF
However, the story did not end there. Two years later, the client suddenly contacted the RCS team, reporting repeated failures during kilogram-scale scale-up. The client's first reaction was to question whether there was an inherent flaw in the process itself.
Facing this doubt, the RCS team did not rush to defend their work. Instead, they calmly analyzed the situation and engaged in detailed technical discussions with the client. Firmly believing in the reliability of their developed process, the team conducted comprehensive validation experiments: 1 g × 2 runs, 10 g × 2 runs, 100 g × 2 runs, and 1000 g × 2 runs. With extremely high execution efficiency, the team quickly and meticulously completed each validation. The results not only reproduced the data from two years prior, but also confirmed that the process stability and reproducibility were better than expected.
To the client's pleasant surprise, the RCS team was not satisfied with merely repeating the validation. During the validation experiments, they proactively explored ways to further optimize the process. Although the route developed two years ago was significantly shorter, each step still required separation and purification. Building upon this, the team introduced continuous processing and precipitation techniques, integrating steps that previously required complex separation and purification into a single, continuous operation and direct product precipitation. This process improvement shortened the cycle time for hundred-gram-scale production from two weeks to just four days, significantly boosting efficiency.
Upon receiving the validation results, the client offered high praise: "It is your outstanding work that made the project simple! This is an excellent achievement." This was not only a recognition of the RCS team's technical expertise and capabilities, but also a sincere appreciation for their relentless pursuit of professional excellence.
Through these two collaborations, the client was completely convinced by the RCS team’s capability in steroid chemistry and process optimization. Following this, the client voluntarily upgraded the partnership into a deep collaboration model, tackling even more challenging steroid molecule syntheses with RCS.
Looking back at the collaboration, it is no coincidence that the WuXi AppTec RCS team won the client's trust. With over a decade of deep involvement, its steroid chemistry platform has built comprehensive technical expertise covering discovery, optimization, process development, and large-scale manufacturing. The platform has accumulated experience from the syntheses of over 10,000 steroid molecules, possessing a profound knowledge base in constructing complex multi-chiral centers and performing precise structural modifications. Furthermore, the platform has established over 20 methods for constructing steroid chiral centers, supported by a rich inventory of advanced steroid intermediates and customized route design capabilities, efficiently enabling steroid drug early discovery efforts including Hit-to-Lead, novel structure development and focused library construction.
Steroid drug research and development has always faced unique challenges: high structural rigidity, high demands for regio- and stereoselectivity, and high difficulty in scale-up. As an enabler, WuXi AppTec’s RCS draws on years of technical expertise to rapidly address thorny issues such as poor regioselectivity and irreproducibility during scale-up, while continuously iterating and optimizing.
Tailoring to the structural characteristics of steroid molecules, the RCS team can achieve systematic research and optimization of candidate molecules through expertise in route development, impurity and metabolite synthesis, isotope labeling, and absolute configuration determination. Meanwhile, the platform supports deliveries ranging from milligrams to kilograms and effectively shortens the development cycle through integration of early process development and scale-up production.
At the same time, the application of steroid molecules continues to expand. These molecules are moving from “receptor agonism or antagonism” to more complex functional regulation, and expanding from single therapeutic effects to diagnostics, drug delivery, and other novel molecular modalities. These new directions, in turn, bring new R&D challenges.

Image Source: 123RF
In response to this trend, the RCS team deeply integrates steroid chemistry with the development of innovative therapeutic modalities, supporting the design and synthesis of steroid skeleton-based antibody-drug conjugates (ADCs), targeted protein degraders, prodrugs, and nitrogen mustard molecules. The platform operates synergistically with analytical services, reaction condition screening, crystallization, flow chemistry, and photoredox and electrochemistry technologies, ensuring a seamless transition from candidate discovery to scalable production. By integrating long-term experience, modular technical capabilities, and cross-platform synergy, the steroid chemistry platform provides clients with stable, efficient, and scalable synthetic solutions, accelerating the R&D of complex steroids and novel conjugate molecules.
More importantly, the RCS team at WuXi AppTec always dares to face challenges and supports clients with professional expertise. In the face of doubt, they do not evade or shift blame; instead, they respond with action and results. Building on already solid achievements, they proactively strive for better, elevating the process from “good” to “excellent.” This relentless pursuit of excellence is a crucial spiritual driving force behind the team's ability to win clients' long-term trust.
From the initial route development to the subsequent validation and upgrade, and now to deep collaboration, WuXi AppTec has consistently fulfilled the team's promise of "strive for excellence" through deliveries that repeatedly exceed expectations. This commitment extends far beyond steroids. It permeates WuXi AppTec’s entire integrated CRDMO platform, driving the company to consistently support every breakthrough of its clients with professionalism and dedication, no matter the complexity of the molecule or the novelty of the therapeutic modality.
